Dr. Jacob Carl

Prix à l'honneur

JUVE Awards 2023

Law firm of the year for IP Law

Jacob is a member of the Patents Technology & Life Sciences Practice Area. He advises international and national companies on intellectual property matters with a focus on patent law. His main focus is on representation in patent infringement proceedings.

Expertise

Services et Groupes

Brevets et innovation

Accords commerciaux brevets et savoir-faire

Résolution des litiges brevets et savoir-faire

Secteurs

Sciences de la vie et Santé

Biotech

Produits pharmaceutiques

CV

Since 2023 Associate, Taylor Wessing

2017 - 2021 Research Associate in a leading IP-Boutique

Carrière

Since 2023 Associate, Taylor Wessing

2017 - 2021 Research Associate in a leading IP-Boutique

Formation

2023 Second state examination, Munich

2021 - 2023 Legal clerkship, Higher Regional Court Munich

2017 - 2022 PhD about the UPC

Publications

Einheitlicher Rechtsschutz Europäischer Patente, Mohr Siebeck, 2023

Langues étrangères

Prix et distinctions

JUVE Awards 2023

Featured

Actualités et publications récentes

View Jacob's insights

Cliquer ici pour en savoir plus

UPC

Territorial Scope of UPC Decisions under Article 34 UPCA: Recent Case Law, Interpretative Trends and Strategic Implications

15 janvier 2026

par plusieurs auteurs

UPC

Pre-trial discovery before the UPC? – Pharmaceuticals, Trade fairs and beyond

19 décembre 2025

In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Taylor Wessing Advises Strangeworks on the Acquisition of Quantagonia

1 septembre 2025

par plusieurs auteurs

Cliquer ici pour en savoir plus

Dr. Jacob Carl

JUVE Awards 2023

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Publications

Langues étrangères

Prix et distinctions

JUVE Awards 2023

Actualités et publications récentes

Territorial Scope of UPC Decisions under Article 34 UPCA: Recent Case Law, Interpretative Trends and Strategic Implications

Related news & insights

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

EU Inc.: Founders and companies with expansion plans must now think strategically

Advising Nuclera on its extended Series C funding to US$87 million

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part one

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part two

Update from Berlin: Federal government tightens cannabis policy

Partner appointment Margot van Gerwen

Data Provision under the Data Act in the Life Sciences Environment

Autres avocats qui pourraient vous intéresser

Rendez-vous à